90 related articles for article (PubMed ID: 19889263)
1. Remission of Grave's disease after oral anti-thyroid drug treatment.
Ishtiaq O; Waseem S; Haque MN; Islam N; Jabbar A
J Coll Physicians Surg Pak; 2009 Nov; 19(11):690-3. PubMed ID: 19889263
[TBL] [Abstract][Full Text] [Related]
2. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the results of treatment of Graves' disease by synthetic antithyroid drugs].
Fischer D; Poncin J; Dunet R; Dry J; Thomas M
Sem Hop; 1977 Oct 9-16; 53(34-35):1843-9. PubMed ID: 73224
[TBL] [Abstract][Full Text] [Related]
5. Predictor of outcome of hyperthyroidism due to Graves disease: serum triiodothyronine/thyroxine ratio.
Khanna CM; Shankar LR; Jaggi CB; Bansal JK; Chugh P
J Assoc Physicians India; 1996 Feb; 44(2):98-101. PubMed ID: 10999059
[TBL] [Abstract][Full Text] [Related]
6. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
7. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
8. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
El Refaei SM; Shawkat W
Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
[TBL] [Abstract][Full Text] [Related]
9. Experience with carbimazole in the treatment of the hyperthyroidism of Graves' disease in Nigerian patients.
Modebe O
Afr J Med Med Sci; 1995 Dec; 24(4):347-51. PubMed ID: 8886149
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
[TBL] [Abstract][Full Text] [Related]
11. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
12. Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission.
Eckstein AK; Lax H; Lösch C; Glowacka D; Plicht M; Mann K; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2007 Oct; 67(4):607-12. PubMed ID: 17880407
[TBL] [Abstract][Full Text] [Related]
13. Logistic multiple regression analysis of factors predicting recurrence of hyperthyroidism after medical treatment of toxic diffuse goitre.
de Rave S; Goldschmidt HM; Bravenboer B; Loosveld OJ; Lockefeer JH
Neth J Med; 1991 Oct; 39(3-4):131-5. PubMed ID: 1791873
[TBL] [Abstract][Full Text] [Related]
14. Predicting the likelihood of remission in children with Graves' disease: a prospective, multicenter study.
Glaser NS; Styne DM;
Pediatrics; 2008 Mar; 121(3):e481-8. PubMed ID: 18267979
[TBL] [Abstract][Full Text] [Related]
15. [Prospective study on the relationship between treatment duration of antithyroid drug and remission rate of Graves' disease].
Liu C; Duan Y; Wu X
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):835-7. PubMed ID: 11218878
[TBL] [Abstract][Full Text] [Related]
16. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
18. Once daily, low dose, short term antithyroid drug treatment of Graves' disease is followed by an unacceptably high relapse rate.
Ford HC; Feek CM; Delahunt JW
N Z Med J; 1991 Mar; 104(907):97-8. PubMed ID: 2006072
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].
Sabri O; Zimny M; Schreckenberger M; Reinartz P; Nowak B; Ostwald E; Schäfer W; Block S; Setani K; Büll U
Nuklearmedizin; 2001 Feb; 40(1):1-6. PubMed ID: 11373933
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
